NG9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neogenomics Inc

Watchlist Manager

Watchlist

Price: 16.745 EUR 0.12% Market Closed

Market Cap: €2.1B

N	Neogenomics Inc F:NG9	US
W	Wyndham Hotels & Resorts Inc F:2WY	US
	Press Metal Aluminium Holdings Bhd OTC:PSSMF	MY
H	Hochtief AG F:HOT	DE
	Hapvida Participacoes e Investimentos SA OTC:HAPVY	BR

Profitability Summary

Neogenomics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

44%

Sustainable 3Y Average Gross Margin

43%

Gross Margin is Increasing

40% > 44%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-21% > -8%

Negative Net Margin

-7%

Negative 3Y Average Net Margin

-13%

Net Margin is Increasing

-21% > -7%

Negative Free Cash Flow Margin

-1%

Negative 3Y Average Free Cash Flow Margin

-4%

Free Cash Flow Margin is Increasing

-12% > -1%

Negative ROE

-6%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7%

ROIC is Increasing

-8% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.